Redox Homeostasis in Muscular Dystrophies

In recent years, growing evidence has suggested a prominent role of oxidative stress in the pathophysiology of several early- and adult-onset muscle disorders, although effective antioxidant treatments are still lacking. Oxidative stress causes cell damage by affecting protein function, membrane structure, lipid metabolism, and DNA integrity, thus interfering with skeletal muscle homeostasis and functionality. Some features related to oxidative stress, such as chronic inflammation, defective regeneration, and mitochondrial damage are shared among most muscular dystrophies, and Nrf2 has been shown to be a central player in antagonizing redox imbalance in several of these disorders. However, the exact mechanisms leading to overproduction of reactive oxygen species and deregulation in the cellular antioxidants system seem to be, to a large extent, disease-specific, and the clarification of these mechanisms in vivo in humans is the cornerstone for the development of targeted antioxidant therapies, which will require testing in appropriately designed clinical trials.

[1]  E. Ricci,et al.  Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy , 2020, International journal of molecular sciences.

[2]  N. Gueven,et al.  Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy , 2020, Redox biology.

[3]  J. Jaiswal,et al.  Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy , 2020, International journal of molecular sciences.

[4]  S. Zierz,et al.  Cellular Stress in the Pathogenesis of Muscular Disorders—From Cause to Consequence , 2020, International journal of molecular sciences.

[5]  M. Rodríguez-Cruz,et al.  Circulating markers of oxidative stress are associated with a muscle injury in patients with muscular dystrophy Duchenne , 2020, Brain and Development.

[6]  E. Esposito,et al.  Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases , 2020, Antioxidants.

[7]  E. Bertini,et al.  Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement , 2020, Biomolecules.

[8]  M. Grounds,et al.  Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress , 2020, Disease Models & Mechanisms.

[9]  O. Slanař,et al.  Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis. , 2020, European journal of pharmacology.

[10]  J. Dowling,et al.  Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies , 2020, Neurology.

[11]  F. Koç,et al.  Antioxidant imbalance in the erythrocytes of Myotonic dystrophy Type 1 patients. , 2019, Archives of biochemistry and biophysics.

[12]  K. O'Halloran,et al.  N-acetylcysteine Decreases Fibrosis and Increases Force-Generating Capacity of mdx Diaphragm , 2019, Antioxidants.

[13]  A. Pichiecchio,et al.  Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging , 2019, Journal of cachexia, sarcopenia and muscle.

[14]  Daniela Sayuri Mizobuti,et al.  Coenzyme Q10 supplementation acts as antioxidant on dystrophic muscle cells , 2019, Cell Stress and Chaperones.

[15]  P. Brambilla,et al.  Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial , 2019, Front. Neurol..

[16]  A. Cuadrado,et al.  Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development , 2019, Oxidative medicine and cellular longevity.

[17]  Min Zhang,et al.  Sulforaphane Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Migration via Suppression of NOX4/ROS/Nrf2 Signaling , 2019, International journal of biological sciences.

[18]  S. Severini,et al.  Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy , 2018, Human molecular genetics.

[19]  R. Tawil,et al.  Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments , 2018, Neurotherapeutics.

[20]  C. Hidalgo,et al.  The signaling pathways underlying BDNF-induced Nrf2 hippocampal nuclear translocation involve ROS, RyR-Mediated Ca2+ signals, ERK and PI3K. , 2018, Biochemical and biophysical research communications.

[21]  I. Nishino,et al.  A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4 , 2018, Human molecular genetics.

[22]  P. Robledo,et al.  Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression. , 2018, Cerebral cortex.

[23]  Katarzyna Pietraszek-Gremplewicz,et al.  Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice. , 2018, Antioxidants & redox signaling.

[24]  Masayuki Yamamoto,et al.  The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. , 2018, Physiological reviews.

[25]  A. Vasconsuelo,et al.  Oxidative Stress in Muscle Diseases: Current and Future Therapy , 2018, Oxidative medicine and cellular longevity.

[26]  E. Ricci,et al.  Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy , 2018, Molecular Neurobiology.

[27]  A. Modesti,et al.  Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds. , 2018, Journal of proteomics.

[28]  G. Meissner The structural basis of ryanodine receptor ion channel function , 2017, The Journal of general physiology.

[29]  M. Grounds,et al.  Pre‐clinical evaluation of N‐acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy , 2017, The Journal of physiology.

[30]  D. Manners,et al.  Mitochondrial dysfunction in myotonic dystrophy type 1 , 2017, Neuromuscular Disorders.

[31]  Daniela Sayuri Mizobuti,et al.  Vitamin E treatment decreases muscle injury in mdx mice. , 2017, Nutrition.

[32]  A. Michelucci,et al.  Antioxidant Treatment Reduces Formation of Structural Cores and Improves Muscle Function in RYR1Y522S/WT Mice , 2017, Oxidative medicine and cellular longevity.

[33]  Takafumi Suzuki,et al.  Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress , 2017, The Journal of Biological Chemistry.

[34]  I. Nonaka,et al.  Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy , 2017, Human molecular genetics.

[35]  V. Pialoux,et al.  Redox Control of Skeletal Muscle Regeneration. , 2017, Antioxidants & redox signaling.

[36]  Z. Ulger,et al.  Serum markers of inflammation and oxidative stress in sarcopenia , 2017, Aging Clinical and Experimental Research.

[37]  E. Bertini,et al.  Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway , 2017, Human molecular genetics.

[38]  Fu-Tsai Chung,et al.  Heat shock protein70 is implicated in modulating NF-κB activation in alveolar macrophages of patients with active pulmonary tuberculosis , 2017, Scientific Reports.

[39]  Amy D. Hanna,et al.  A chemical chaperone improves muscle function in mice with a RyR1 mutation , 2017, Nature Communications.

[40]  Akhileshwar Namani,et al.  Nrf2 signaling pathway: Pivotal roles in inflammation. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[41]  Donna D. Zhang,et al.  NRF2-targeted therapeutics: New targets and modes of NRF2 regulation. , 2016, Current opinion in toxicology.

[42]  Saumya Das,et al.  Heme oxygenase and carbon monoxide protect from muscle dystrophy , 2016, Skeletal Muscle.

[43]  M. Lipinski,et al.  DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients. , 2016, Free radical biology & medicine.

[44]  Francesco Muntoni,et al.  An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities , 2016, Science Signaling.

[45]  K. Nakayama,et al.  Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription , 2016, Nature Communications.

[46]  M. Lipinski,et al.  Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage , 2016, Histochemistry and Cell Biology.

[47]  R. Taneja,et al.  Oxidative Stress-Mediated Skeletal Muscle Degeneration: Molecules, Mechanisms, and Therapies , 2015, Oxidative medicine and cellular longevity.

[48]  Katarzyna Pietraszek-Gremplewicz,et al.  The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes , 2015, Journal of Muscle Research and Cell Motility.

[49]  Takafumi Suzuki,et al.  Molecular basis of the Keap1-Nrf2 system. , 2015, Free radical biology & medicine.

[50]  B. Engelen,et al.  RYR1‐related myopathies: a wide spectrum of phenotypes throughout life , 2015, European journal of neurology.

[51]  Dejia Li,et al.  Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway* , 2015, The Journal of Biological Chemistry.

[52]  S. Movafagh,et al.  Regulation of Hypoxia‐Inducible Factor‐1a by Reactive Oxygen Species : New Developments in an Old Debate , 2015, Journal of cellular biochemistry.

[53]  Daniela Sayuri Mizobuti,et al.  Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells , 2015, Redox report : communications in free radical research.

[54]  Ying Zhang,et al.  Nrf2 regulates ROS production by mitochondria and NADPH oxidase , 2015, Biochimica et biophysica acta.

[55]  J. Pincemail,et al.  Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial. , 2015, Free radical biology & medicine.

[56]  S. Severini,et al.  β-catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy , 2015, Journal of The Royal Society Interface.

[57]  S. Iannaccone,et al.  Congenital myopathies and muscular dystrophies. , 2014, Neurologic clinics.

[58]  M. Tarnopolsky,et al.  Redox State and Mitochondrial Respiratory Chain Function in Skeletal Muscle of LGMD2A Patients , 2014, PloS one.

[59]  D. Rajakumar,et al.  Involvement of oxidative stress, nuclear factor kappa B and the ubiquitin proteasomal pathway in dysferlinopathy. , 2014, Life sciences.

[60]  M. Sardiello,et al.  Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy , 2014, Nature Communications.

[61]  E. Mercuri,et al.  Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy , 2014, PloS one.

[62]  F. Di Lisa,et al.  Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets , 2014, Journal of Muscle Research and Cell Motility.

[63]  Michael Kyba,et al.  High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity , 2014, Skeletal Muscle.

[64]  S. Agarwal,et al.  Imbalanced oxidant and antioxidant ratio in myotonic dystrophy type 1 , 2014, Free radical research.

[65]  Ching H. Wang,et al.  Diagnostic approach to the congenital muscular dystrophies , 2014, Neuromuscular Disorders.

[66]  P. Shieh Muscular dystrophies and other genetic myopathies. , 2013, Neurologic clinics.

[67]  M. Grounds,et al.  Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies , 2013, The FEBS journal.

[68]  D. Rajakumar,et al.  Oxidative Stress, NF-κB and the Ubiquitin Proteasomal Pathway in the Pathology of Calpainopathy , 2013, Neurochemical Research.

[69]  Yi-Wen Chen,et al.  DUX4 Differentially Regulates Transcriptomes of Human Rhabdomyosarcoma and Mouse C2C12 Cells , 2013, PloS one.

[70]  J. Lawler,et al.  Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy , 2013, Journal of Muscle Research and Cell Motility.

[71]  B. Vernus,et al.  Glutathione peroxidase 3, a new retinoid target gene, is crucial for human skeletal muscle precursor cell survival , 2012, Journal of Cell Science.

[72]  C. Reggiani,et al.  Inflammation in muscular dystrophy and the beneficial effects of non‐steroidal anti‐inflammatory drugs , 2012, Muscle & nerve.

[73]  R. Krahe,et al.  The myotonic dystrophies: molecular, clinical, and therapeutic challenges , 2012, The Lancet Neurology.

[74]  J. Pincemail,et al.  Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. , 2012, Free radical biology & medicine.

[75]  J. Y. Kuwada,et al.  Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. , 2012, Brain : a journal of neurology.

[76]  P. Sestili,et al.  Reactive Oxygen Species in Skeletal Muscle Signaling , 2011, Journal of signal transduction.

[77]  Christopher W Ward,et al.  X-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart , 2011, Science.

[78]  J. Lainé,et al.  Increased Muscle Stress-Sensitivity Induced by Selenoprotein N Inactivation in Mouse: A Mammalian Model for SEPN1-Related Myopathy , 2011, PloS one.

[79]  T. Shiomi,et al.  Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. , 2011, Cell metabolism.

[80]  Raffaele Iorio,et al.  CD8+ T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI , 2011, Journal of Clinical Immunology.

[81]  D. Allen,et al.  Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx Mouse , 2010, PloS one.

[82]  T. Kensler,et al.  When NRF2 talks, who's listening? , 2010, Antioxidants & redox signaling.

[83]  Daniel G. Miller,et al.  A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy , 2010, Science.

[84]  A. Musarò,et al.  Oxidative stress and muscle homeostasis , 2010, Current opinion in clinical nutrition and metabolic care.

[85]  M. Ehrlich,et al.  Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei , 2010, European Journal of Human Genetics.

[86]  A. Ferreiro,et al.  Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. , 2010, Antioxidants & redox signaling.

[87]  R. Finkel,et al.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.

[88]  R. Haller,et al.  Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle. , 2009, Human molecular genetics.

[89]  F. Muntoni,et al.  Oxidative stress in SEPN1‐related myopathy: From pathophysiology to treatment , 2009, Annals of neurology.

[90]  M. Kyba,et al.  An isogenetic myoblast expression screen identifies DUX4‐mediated FSHD‐associated molecular pathologies , 2008, The EMBO journal.

[91]  F. Muntoni,et al.  Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. , 2008, Current opinion in pharmacology.

[92]  A. E. Rossi,et al.  RyR1 S-Nitrosylation Underlies Environmental Heat Stroke and Sudden Death in Y522S RyR1 Knockin Mice , 2008, Cell.

[93]  J. Viña,et al.  Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. , 2008, Free radical biology & medicine.

[94]  L. Morrison Unraveling RYR1 mutations and muscle biopsies , 2008, Neurology.

[95]  Michiaki Yamashita,et al.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. , 2007, The Journal of clinical investigation.

[96]  D. Allen,et al.  The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[97]  M. Tarnopolsky,et al.  Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice. , 2007, Free radical biology & medicine.

[98]  G. Vita,et al.  RAGE‐NF‐κB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy , 2007 .

[99]  S. Hamilton,et al.  Identification of Cysteines Involved in S-Nitrosylation, S-Glutathionylation, and Oxidation to Disulfides in Ryanodine Receptor Type 1* , 2006, Journal of Biological Chemistry.

[100]  J. Engelhardt,et al.  Interleukin-1β Induction of NFκB Is Partially Regulated by H2O2-mediated Activation of NFκB-inducing Kinase* , 2006, Journal of Biological Chemistry.

[101]  S. Messina,et al.  Oxidative stress in myotonic dystrophy type 1 , 2005, Free radical research.

[102]  C. Bisbal,et al.  Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle , 2005, Journal of Molecular Medicine.

[103]  Y. Naito,et al.  Oxidative stress and delayed-onset muscle damage after exercise. , 2004, Free radical biology & medicine.

[104]  P. Brecher,et al.  Temporal Control of NF-κB Activation by ERK Differentially Regulates Interleukin-1β-induced Gene Expression* , 2004, Journal of Biological Chemistry.

[105]  S. Winokur,et al.  Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress , 2003, Neuromuscular Disorders.

[106]  P. Hasselgren,et al.  IL-1β stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-κB , 2003 .

[107]  Michael R. Green,et al.  Inappropriate Gene Activation in FSHD A Repressor Complex Binds a Chromosomal Repeat Deleted in Dystrophic Muscle , 2002, Cell.

[108]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[109]  K. Davies Oxidative Stress, Antioxidant Defenses, and Damage Removal, Repair, and Replacement Systems , 2000, IUBMB life.

[110]  M. Leppert,et al.  Congenital muscular dystrophy with rigid spine syndrome: A clinical, pathological, radiological, and genetic study , 2000, Annals of neurology.

[111]  S. Ishiura,et al.  Differential signaling pathways following oxidative stress in mutant myotonin protein kinase cDNA-transfected C2C12 cell lines. , 2000, Biochemical and biophysical research communications.

[112]  R. Foresti,et al.  Heme oxygenase-1 induction in skeletal muscle cells: hemin and sodium nitroprusside are regulators in vitro. , 1998, American journal of physiology. Cell physiology.

[113]  T. Rando,et al.  Muscle cells from mdx mice have an increased susceptibility to oxidative stress , 1998, Neuromuscular Disorders.

[114]  Keiko Sato,et al.  Free radicals, lipid peroxides and antioxidants in blood of patients with myotonic dystrophy , 1995, Journal of Neurology.

[115]  G. Dudley,et al.  Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. , 1994, The American journal of physiology.

[116]  K. Campbell,et al.  Dystrophin–glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophies , 1994, Muscle & nerve.

[117]  J E Hewitt,et al.  FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. , 1993, Human molecular genetics.

[118]  J. Weber,et al.  Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. , 1991, Genomics.

[119]  J. Pincemail,et al.  [Oxidative stress]. , 2007, Revue medicale de Liege.

[120]  I. Hausmanowa-Petrusewicz,et al.  The involvement of oxidative stress in determining the severity and progress of pathological processes in dystrophin-deficient muscles. , 2005, Acta biochimica Polonica.

[121]  A. Dinkova-Kostova,et al.  Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. , 2004, Advances in enzyme regulation.

[122]  S. Hamilton,et al.  RyR1 modulation by oxidation and calmodulin. , 2000, Antioxidants & redox signaling.